PDCO
60
2
MSFT
60
2
TDC
62
2
TGNA
45
2
QRVO
63
7
AEE
43
2
IPG
62
4
AAL
33
-3
ACN
34
-4
GOOG
81
2
WRK
59
3
GT
50
-2
URI
53
-3
EXC
63
-3
FE
48
2
VLO
33
-3
CHK
41
7
TXT
60
-9
FRT
55
4
UNM
68
-4
PDCO
60
2
MSFT
60
2
TDC
62
2
TGNA
45
2
QRVO
63
7
AEE
43
2
IPG
62
4
AAL
33
-3
ACN
34
-4
GOOG
81
2
WRK
59
3
GT
50
-2
URI
53
-3
EXC
63
-3
FE
48
2
VLO
33
-3
CHK
41
7
TXT
60
-9
FRT
55
4
UNM
68
-4
Financhill
Back

Akero Therapeutics Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
25

AKRO
Akero Therapeutics

Last Price:
18.92
Seasonality Move:
16.15%
Sell
46

CPRX
Catalyst Pharmaceuticals

Last Price:
14.69
Seasonality Move:
2.11%
Sell
25
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $20.26. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $15.12. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $20.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $15.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.21 Sell
Relative Strength Index (14 RSI): 31.81 Sell
Chaikin Money Flow: -465905 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.28 - 24.52) Sell
Bollinger Bands (100): (20 - 26.08) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 45.75 Sell
Chaikin Money Flow: 672436 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.13 - 16.11) Sell
Bollinger Bands (100): (14.04 - 16.2) Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.06 Sell
20-day SMA: 22.39 Sell
50-day SMA: 24.65 Sell
200-day SMA: 29.08 Sell
8-day EMA: 21.09 Sell
20-day EMA: 22.3 Sell
50-day EMA: 23.39 Sell
200-day EMA: 27.61 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.29 Sell
20-day SMA: 15.48 Sell
50-day SMA: 15.44 Sell
200-day SMA: 14.19 Buy
8-day EMA: 15.22 Sell
20-day EMA: 15.43 Sell
50-day EMA: 15.37 Sell
200-day EMA: 14.58 Buy

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):